Syncra read · NCT05303519

Syncra read on SIGMA

Sponsor
Nuvation Bio
Indication
Advanced solid tumors and hematologic malignancies
Phase
Phase I / II
365/365 enrolled · last updated Wed Jul 01
78 High Risk Live